COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,224 Articles (22,733 medRxiv, 8,491 bioRxiv)

Most recent first Previous |  Page 2843: Articles 28421-28430  | Next

Three CoViD-19 Mortality Indicators for Temporal and International Comparisons
Heuveline, P., Tzen, M.
10.1101/2020.04.29.20085506 — Posted: 2020-05-05
Homegrown Ultraviolet Germicidal Irradiation for Hospital-Based N95 Decontamination during the COVID-19 Pandemic
Schnell, E., Harriff, M. J., Yates, J. E., Karamooz, E., Pfeiffer, C. D., McCarthy, J., Trapp, C. L., Frazier, S. K., Dodier, J. E., Smith, S. M.
10.1101/2020.04.29.20085456 — Posted: 2020-05-05
Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region
Wajnberg, A., Mansour, M., Leven, E., Bouvier, N. M., Patel, G., Firpo, A., Mendu, R., Jhang, J., Arinsburg, S., Gitman, M., Houldsworth, J., Baine, I., Simon, V., Aberg, J., Krammer, F., Reich, D., Cordon-Cardo, C.
10.1101/2020.04.30.20085613 — Posted: 2020-05-05 Discussion: Onsite
Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: a retrospective study
Yin, R., Yang, Z., Wei, Y., Li, Y., Chen, H., Ma, D., Dan, M., Zhang, Y., Liu, X., Leng, H., Xiang, D.
10.1101/2020.04.29.20085415 — Posted: 2020-05-05
Preliminary Results of Seroprevalence of SARS-CoV-2 at Community Clinics in Tokyo
Takita, M., Matsumura, T., Yamamoto, K., Yamashita, E., Hosoda, K., Hamaki, T., Kusumi, E.
10.1101/2020.04.29.20085449 — Posted: 2020-05-05 Discussion: Onsite
Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam
Wong, J., Koh, W. C., Momin, R. N., Alikhan, M. F., Fadillah, N., Naing, L.
10.1101/2020.04.30.20086082 — Posted: 2020-05-05
Characteristics of lymphocyte subsets and their predicting values for the severity of COVID-19 patients
Wang, J., Dong, X., Zhang, B., Yang, X., Li, Z., Wang, X., Zuo, S.
10.1101/2020.05.01.20086421 — Posted: 2020-05-05 Discussion: Onsite | Offsite
AN INTERACTIVE COVID-19 MOBILITY IMPACT AND SOCIAL DISTANCING ANALYSIS PLATFORM
Zhang, L., Ghader, S., Pack, M. L., Xiong, C., Darzi, A., Yang, M., Sun, Q., Kabiri, A., Hu, S.
10.1101/2020.04.29.20085472 — Posted: 2020-05-05
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Vuagnat, P., Frelaut, M., Ramtohul, T., Basse, C., Diakite, S., Noret, A., Bellesoeur, A., Servois, V., Hequet, D., Laas, E., Kirova, Y., Cabel, L., Pierga, J.-Y., Institut Curie Breast Cancer and COVID Group, , Bozec, L., Paoletti, X., Cottu, P., Bidard, F.-C.
10.1101/2020.04.30.20085928 — Posted: 2020-05-05
Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia
Mohamad, E. M., Azlan, A. A., Hamzah, M. R., Tham, J. S., Ayub, S. H.
10.1101/2020.04.29.20085563 — Posted: 2020-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).